Skip to main content

Table 1 Comparisons of variables between patients with and without plaque

From: The impact of identifying carotid plaque on addressing cardiovascular risk in psoriatic arthritis

  

No plaque

Plaque

 

Factor

Total N assessed

N

Statistics

N

Statistics

p valuea

Ageb

87

53

49.58 ± 10.56

34

58 ± 8.58

<0.001T

Male sexc

87

26

49.06

15

44.12

0.82C

History of hypertensionc

86

17

32.69

23

67.65

0.003C

BP < 140/90 mmHgc

87

42

79.25

20

58.82

0.07C

Smoking statusc

87

    

0.052C

 No

44

29

54.72

15

44.12

 

 Former

26

18

33.96

8

23.53

 

 Current

17

6

11.32

11

32.35

 

BMIb

79

47

30.87 ± 8.54

32

30.34 ± 6.16

0.75T

Diabetesc

87

7

13.21

9

26.47

0.20C

Total cholesterolb

75

44

184.5 ± 29.31

31

202.48 ± 45.16

0.057T

Triglycerided

74

43

95 (70, 125)

31

144 (87.5, 177.5)

0.014W

HDLb

74

43

55.12 ± 15.49

31

56.16 ± 21.55

0.82T

LDLb

74

43

104.07 ± 26.35

31

118.74 ± 41.94

0.092T

Antiplatelet usec

87

14

26.42

10

29.41

0.95C

Statin usec

87

9

16.98

10

29.41

0.27C

Biologic usec

87

    

0.03F

 No

17

14

26.42

3

8.82

 

 Former

5

1

1.89

4

11.76

 

 Current

65

38

71.7

27

79.41

 

Traditional DMARD usec

87

    

0.75F

 No

11

7

13.21

4

11.76

 

 Former

34

19

35.85

15

44.12

 

 Current

42

27

50.94

15

44.12

 

History of CVDc

87

2

3.77

5

14.71

0.11F

ESRd

69

37

8 (4, 10)

32

8 (5.25, 12.25)

0.53W

CRPd

84

52

0.3 (0.1, 0.6)

32

0.3 (0.2, 1.22)

0.11W

PsO durationb

85

52

21.02 ± 14.79

33

22.58 ± 19.14

0.69T

PsA durationb

84

51

10.76 ± 8.32

33

12.76 ± 10.7

0.37T

Prednisone use > 1 monthc

86

26

49.06

11

33.33

0.23C

Current NSAID usec

87

27

50.94

22

64.71

0.30C

Baseline SJCd

81

49

1 (0, 5)

32

0 (0, 4.5)

0.88W

Baseline TJCd

81

49

5 (0, 14)

32

5 (0.75, 16.25)

0.93W

  1. a C Pearson’s chi-squared test with Yates’ continuity correction, F Fisher’s exact test for count data, T Welch Two Sample T-test, W Wilcoxon rank sum test with continuity correction
  2. bMean ± SD
  3. cPercentage
  4. dMedian (25th percentile, 75th percentile)
  5. BP blood pressure, CRP C-reactive protein, CVD cardiovascular disease, DMARD disease-modifying antirheumatic drug, ESR erythrocyte sedimentation rate, HDL high-density lipoprotein, LDL low-density lipoprotein, NSAID nonsteroidal anti-inflammatory drug, PsA psoriatic arthritis, SJC swollen joint count, TJC tender joint count PsO psoriasis